📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

HTT-lowering reverses Huntington's disease immune dysfunction caused by NF?B pathway dysregulation. (2014)

First Author: Träger U

Attributed to: Targeting the innate immune system in Huntington's disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/brain/awt355

PubMed Identifier: 24459107

Publication URI: http://europepmc.org/abstract/MED/24459107

Type: Journal Article/Review

Volume: 137

Parent Publication: Brain : a journal of neurology

Issue: Pt 3

ISSN: 0006-8950